Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

WFNOS Magazine

The inaugural issue of the official publication of the World Federation of Neuro-Oncology Societies is ...

Read Full Story

Neuro-Oncology Review Course at SNO

November 16, 2016. Register in conjunction with the SNO Annual Meeting

Read Full Story

CNS Anticancer Drug Discovery and Development Conference

Register Now!

Read Full Story
View All News


EANO 2016

Read Full Story


18th Annual Brain Tumor Update and 7th Annual International Symposium on Long-Term Control of Metastases to the Brain and Spine

Read Full Story


2nd CNS Anticancer Drug Discovery/Development Conference

Read Full Story

2015 Industry Supported Symposia


At the 20th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO), there will be multiple Industry Supported Symposia (ISS) Sessions.  Lunch-time ISS sessions will be held on Friday and Saturday and evening ISS sessions will be held on Thursday and Friday evenings. 


Lunch Sessions


Friday, November 20, 2015: 12:15pm - 1:15pm


VB‐111, a Novel Gene Therapeutic for rGBM: From Bench to Pivotal Phase 3 GLOBE Trial
Supported by Vascular Biogenics Ltd.
Room: Salon GM 

Prof. Dror Harats, MD
CEO, VBL Therapeutics

Dr. Yael Cohen, MD
VP Clinical Development, VBL Therapeutics

Dr. Andrew Brenner, MD, PhD
UTHSCSA, CTRC, San Antonio, TX

Dr. Tim Cloughesy, MD
UCLA, Los Angeles, CA


Glioblastoma in 2015: A New Year and New Strategies
Supported by a grant from Novocure
Room: Salon E-F 

Jeffrey Raizer, MD
Northwestern University, Chicago, Illinois

Jeremy Rudnick, MD
Cedars-Sinai Medical Center, Los Angeles, California

Joon H. Uhm, MD
Mayo Clinic, Rochester, Minnesota

To register for this ISS prior to SNO Meeting, click here.


Gliomas, Meningiomas & More: The Increasing Relevance of Radiosurgery
Supported by Elekta
Room: Salon H-L  

Radiosurgery for Malignant Glioma
Dr. Ajay Niranjan, University of Pittsburgh

Prediction Parameters of Radiosurgery for Meningioma
Dr. Gelareh Zadeh, University of Toronto

Radiosurgery of Pituitary Tumor
Dr Jonathan Knisely, North Shore LIJ Health System

Case Based Multidisciplinary Management of Pituitary Tumors
Dr. Karolyn Au, University of Toronto



Saturday, November 21, 2015: 12:15pm - 1:15pm


A Milestone in Glioblastoma Treatment
Supported by Novocure 
Room: Salon H-L

Steven A. Toms, MD, MPH, FAANS, FACS
Associate Chief Medical Officer
Director, Department of Neurological Surgery|
Co-Director, Neuroscience Institute
Geisinger Health System

Suriya Jeyapalan, MD
Director of Medical Neuro-Oncology
Tufts Medical Center

To register for this ISS prior to SNO Meeting, click here.


Controversies in Lymphomatous Meningitis
Supported by a grant from Sigma-Tau Pharmaceuticals, Inc. 
Room: CR 17-18

Manmeet Ahluwalia, MD, FACP
Cleveland Clinic, Cleveland, Ohio

Michael Glantz, MD
Penn State University, Hershey Medical Center
Hershey, Pennsylvania

Maciej Mrugala, MD, PhD, MPH
Fred Hutchinson Cancer Research Center
University of Washington
Seattle, Washington

To register for this ISS prior to SNO Meeting, click here.


Evening Sessions


 Thursday, November 19, 2015:  5:30pm - 7:30pm


Immunotherapy in Glioblastoma: Emerging Options in Precision Medicine
Supported by a grant from Celldex Therapeutics
Room: Salon HKL 

John H. Sampson, MD, PhD
Duke University, Durham, NC

Amy B. Heimberger, MD
MD Anderson Cancer Center, Houston, TX

Michael Weller, MD
University Hospital of Zürich, Zürich, Switzerland

To register for this ISS prior to SNO Meeting, click here.


Glioblastoma Tumor Panel and Journal Club: Clinical Investigators Provide Perspectives on Current Cases from Their Practices and Important Recent Publications and Presentations
Supported by grants from AbbVie Inc, Genentech BioOncology and Novocure
Room: Salon E-F 

Minesh Mehta, MD
Tom Mikkelsen, MD
Jeffrey Raizer, MD
Patrick Y Wen, MD
Zvi Ram, MD

Dr Neil Love

To register for this ISS prior to the SNO Annual Meeting, click here. Onsite registration will be open starting at 3:00 PM (Central Time) on Thursday, November 19th located in the foyer of the Grand Ballroom — Salon E-F (3rd Floor) at the Marriott Rivercenter.  


Friday, November 20, 2015:  5:30pm - 7:30pm


Immuno-Oncology: Emerging Research in Primary and Secondary Brain Tumors
Supported by Bristol-Myers Squibb
Room: Salon E-F (Level 3 of Marriott Rivercenter)

Harnessing the Immune System in Cancer Research and Current Challenges in Treating CNS Tumors 
John Sampson, MD, PhD 
Duke University School of Medicine

Mechanisms of Immunosuppression in Glioblastoma
Peter Fecci, MD, PhD
Duke University Medical Center

Treatment Strategies Under Evaluation in Glioblastoma
Michael Lim, MD
Johns Hopkins School of Medicine

Emerging Clinical Investigations of Immunotherapy in Glioblastoma
John Sampson, MD, PhD
Duke University School of Medicine

Future Considerations for Immuno-Oncology in Primary and Secondary Brain Tumors
David Reardon, MD
Dana-Farber Cancer Institute

To register, visit the registration desk in the Prefunction area onsite at the SNO Meeting


Novalis Circle Symposium: Technical and Clinical Validation of Integrated Surgery and Radiosurgery for Benign Brain Tumors
Supported by Brainlab
Room: Salon H-L (Level 3 of Marriott Rivercenter)

Personalized Treatment Based on Natural History for Complex Skull Base Tumors
Isaac Yang, MD

Intra-Operative Imaging with Navigation Software Only: Clinical Evaluation of Intra-Operative Structure Update
Joerg-Christian Tonn, MD

Adaptive Hybrid Surgery Management of Complex Skull Base Tumors
Orin Bloch, MD

To register for this ISS prior to SNO Meeting, click here.